Ronaldo_CFF Profile Banner
Ronaldo Correa Fabiano Profile
Ronaldo Correa Fabiano

@Ronaldo_CFF

Followers
833
Following
3K
Media
104
Statuses
671

Brigham and Women's hospitalist @BrighamW | IM @UPMC | Former Postdoc - MGH | #Cardiology #MedEd @CardioNerds Academy Chief (views = my own)

Boston, MA
Joined February 2019
Don't wanna be here? Send us removal request.
@Ronaldo_CFF
Ronaldo Correa Fabiano
3 years
⁉️ Colchicine, an old drug with a new purpose? A quick review of colchicine use in cardiovascular disease πŸ«€ Follow the 🧡(1/24) #CardioTwitter #FOAMed #MedTwitter
4
59
161
@OHSUCardFellows
OHSU Cardiology Fellowship
5 days
We are soooo happy to welcome our new fellows who have matched with us!! 6 amazing new general fellows and 6 incredible advanced fellows! Welcome to the family πŸ₯°πŸ₯°β€οΈβ€οΈ
2
3
22
@Ronaldo_CFF
Ronaldo Correa Fabiano
1 month
πŸ”₯ Happy to share our manuscript @LancetRH_Americ WHtR was superior to BMI in predicting atherosclerosis Thiago Mendes @generosoMD @brunohalpern Carolina Janovsky, @carlosmanuelro @rauldsf_santos Isabela Bensenor @PauloLotufo @MBittencourtMD https://t.co/Lw7t5QTN9t
1
2
7
@atherosociety
International Atherosclerosis Society (IAS)
3 months
The International Atherosclerosis Society has partnered with π˜•π˜’π˜΅π˜Άπ˜³π˜¦ π˜™π˜¦π˜·π˜ͺ𝘦𝘸𝘴 𝘊𝘒𝘳π˜₯π˜ͺ𝘰𝘭𝘰𝘨𝘺 for an initiative aimed at providing early-career researchers with the experience of the academic publishing process. π—¦π˜‚π—―π—Ίπ—Άπ˜€π˜€π—Άπ—Όπ—»π˜€ 𝗳𝗿𝗼𝗺
0
4
11
@rauldsf_santos
Raul Santos
3 months
Great opportunity to have discussed assess to secondary prevention measures in low and middle income countries @worldheartfed Heart Cafe! @escardio @atherosociety
0
4
19
@purviparwani
Dr. Purvi Parwani
3 months
#ESCCongress Pericarditis treatment First-Line Therapy 🌞 NSAIDs (or aspirin) + colchicine remain the mainstay for treating acute and recurrent pericarditis. 🌞 Colchicine should be continued for 3 months after a first episode and 6–12 months for recurrent cases.
2
55
194
@SamiaMoraMD
Samia Mora
3 months
Looking forward to meeting this amazing group of fellows coming from around the world for the first ever #InflammationAcademy organized by @atherosociety (#FITs stay tuned for future activities) #ESCCongress
@atherosociety
International Atherosclerosis Society (IAS)
3 months
The countdown to IAS' #InflammationAcademy is on! In just three days, the first cohort of fellows will come together in Madrid to learn from some of the most influential voices in #inflammation and #cardiometabolic health. Thank you to instructors Peter Libby, MD, Cristina
2
3
27
@Ronaldo_CFF
Ronaldo Correa Fabiano
4 months
πŸ”–2025 Annual Alan Lerner Research Symposium @BrighamWomens ❀️‍πŸ”₯GlycA Predicts CV Events - VITAL TRIAL Insights Many thanks to my mentor @SamiaMoraMD and her incredible multidisciplinary team!
2
2
24
@gmvasilakis
Georgia Vasilakis Tsatiris, MD
7 months
πŸ₯ You're seeing a new patient with fevers, tachycardia, a new murmur. Not a Janeway lesion or splinter hemorrhage in sight... βœ‹πŸ©Έ ...Now what? πŸ™€ Time for a #Tweetorial on the role of Multimodality #CardiacImaging in #InfectiveEndocarditis (via 2023 ESC Guidelines) 🧡
1
11
27
@n_marreromed
Natalie Marrero
8 months
Excited to advance my knowledge in lipidology and connect with leaders in the field πŸ«€#NLA #lipids
@nationallipid
National Lipid Association
8 months
Congrats to the 2025 Lipid Scholarship Program (LSP) recipients!πŸŽ‰ With 84 applicants and just 15 selected, this was our most competitive year yet. We’re so proud of this program’s growth β€” cheers to the future of #lipidology!
1
1
13
@Gurleen_Kaur96
Gurleen Kaur, MD
8 months
10 days left to apply for the @CardioNerds Academy! Joining CardioNerds was one of the best decisions I’ve made! 🌟Endless learning 🌟Personal & professional growth 🌟A community of cherished friends & mentors
@Gurleen_Kaur96
Gurleen Kaur, MD
9 months
Applications for the next cohort of the @CardioNerds Academy are due April 28th! 🌟 Revised curriculum tailored to the evolving landscape of digital MedEd 🌟 Develop skills in scientific writing, visual graphic creation, & podcast development πŸ”— https://t.co/K1ICGwpnUq
1
11
36
@RonBlankstein
Ron Blankstein
8 months
Congrats to @Gurleen_Kaur96 who led our latest #MGBLpaRegistry paper showing that ⬆️Lp(a) is a/w higher rates of CVD & MI in both women and men. Our findings suggest that ⬆️Lp(a) may pose a higher relative risk in post menopausal women (vs. younger women)
7
18
126
@BrunoLimaMDPhD
Bruno Lima
8 months
I can’t think of someone more deserving of this award then Ron Blankstein. Lifetime mentor of us all. #YesCCT
4
14
68
@goodmra1
Rachel Goodman
8 months
TOMORROW! (23 hrs and 49 mins) Come hang out and learn about LV unloading in AMI shock from @NavinKapur4 @ShashankSinhaMD @rachkataria & @tonkhueMdPhd. ➑️ Register here: https://t.co/8LayX3IUNa πŸ—“οΈ Tuesday April 15 (tomorrow!) ⏰ 8PM EST
0
17
60
@goodmra1
Rachel Goodman
8 months
Fun fact: I frequently tell @NAVINKAPUR1 that I find PCIs boring (πŸ‘€) and he STILL mentors me and agreed to hang out with us at @CardioNerds. (He also gives me all the RHCs πŸ‘ŠπŸ»πŸ¦’.) JOIN US NEXT WEEK! ➑️ Register here: https://t.co/8LayX3IUNa πŸ—“οΈ Tuesday April 15 ⏰ 8PM EST
1
8
27
@carlarod0715
Carla Rodriguez
8 months
πŸ”ΆSmall Vessels, Big Impact!πŸ”Ά Check out this new infographic on the pathophysiology, diagnosis and treatment of Coronary Microvascular Disease πŸ«€ #HeartHealth #CMD Thank you to @CardioNerds, @goodmra1 and @AmitGoyalMD for their review!
0
14
20
@Gurleen_Kaur96
Gurleen Kaur, MD
9 months
Applications for the next cohort of the @CardioNerds Academy are due April 28th! 🌟 Revised curriculum tailored to the evolving landscape of digital MedEd 🌟 Develop skills in scientific writing, visual graphic creation, & podcast development πŸ”— https://t.co/K1ICGwpnUq
1
44
121
@Dr_DanMD
Daniel Ambinder, MD
9 months
πŸ“š412: @CardioNerds – Biology of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) πŸ’‘ Join @RichardAFerraro, @a_radakrishnan & explore the biology of ATTR-CM with Dr. Daniel Judge. πŸ«€ Produced in collab with @ASPCardio πŸ™Audio editing- @marques_julia_ https://t.co/calHWy3xWm
Tweet card summary image
cardionerds.com
Explore the biology of transthyretin amyloid cardiomyopathy with Dr. Daniel Judge covering pathophysiology, diagnosis, and treatment advances.
0
13
39
@AmitGoyalMD
Amit Goyal MD MAS
9 months
🚨Just in at #USCardiology - a statement from the @CardioNerds Academy: "Navigating Digital Medical Education in the Current Era: Process Over Platform" by @Gurleen_Kaur96 @TxID_Edu @TommyMD & @CardioNerds Academy Leadershipβ™₯οΈπŸ€“
1
20
47
@a_radakrishnan
Anna Radakrishnan, MD, MBA
10 months
🚨Women have nearly 2x the lifetime risk of HFpEF vs HFrEF β€” yet research, diagnosis, and treatment strategies still lag behind‼️Our new review explores the cardiometabolic drivers of HFpEF in women, co-published in @JCardFail & @AJPCardioπŸ«€βœ¨ #FunctionNotFailure🀝#CVPrev
Tweet card summary image
onlinejcf.com
Heart failure with preserved ejection fraction (HFpEF) represents a major clinical challenge with rising global prevalence. Women have a nearly double lifetime risk of developing HFpEF compared to...
2
18
63